SCHEMBL11025566

SCHEMBL11025566

Cc1ccc(C2CC(C)(C)c3cc(Cl)cc(C(N)=O)c3N2)cc1N1CCCC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.37
▸ KMT2A Q03164 4/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ MAPT P10636 4/20 0.36
▸ THRB P10828 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ GFER P55789 1/20 0.36
▸ YWHAG P61981 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ NR1H4 Q96RI1 1/20 0.36
▸ HTT P42858 1/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ TP53 P04637 3/20 0.35
▸ AR P10275 3/20 0.33
▸ GPR55 Q9Y2T6 1/20 0.33
▸ MCOLN3 Q8TDD5 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ LMNA P02545 1/20 0.32
▸ GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11029114 0.89 MAPT (0.36) MEN1KMT2AALDH1A1MAPTTHRB
SCHEMBL11022437 0.86 SCN9A (0.35) MEN1KMT2AALDH1A1MAPTNR1H4
SCHEMBL11030190 0.84 HTR1A (0.36) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL11025564 0.83 CDC7 (0.35) MEN1KMT2AALDH1A1MAPTTHRB
SCHEMBL11025415 0.76 CYP2C19 (0.41) MEN1KMT2AALDH1A1MAPTCYP3A4
SCHEMBL11026178 0.76 HTR7 (0.34) MAPTARLMNA
SCHEMBL11021499 0.76 ALDH1A1 (0.39) MEN1KMT2AALDH1A1MAPTKDM4E
SCHEMBL11031120 0.75 F11 (0.34) ALDH1A1KDM4EHTTGAA
SCHEMBL11029096 0.74 CDC7 (0.35) MEN1KMT2AALDH1A1MAPTTHRB
SCHEMBL11029142 0.73 PARP1 (0.35) MEN1KMT2AALDH1A1KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8809369-B2 Tetrahydroquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2014-08-19 — — US claimed
US-20120190677-A1 NOVEL TETRAHYDROQUINOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — US claimed
US-8809369-B2 Tetrahydroquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2014-08-19 — — US disclosed
US-20120190677-A1 NOVEL TETRAHYDROQUINOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190677-A1 NOVEL TETRAHYDROQUINOLINE DERIVATIVES RAB1A, RABL3, RAB7A MEN1 487/4885KMT2A 513/4885ALDH1A1 785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback